SynthesisDigestive diseases and sciences2026

Efficacy and Safety of Risankizumab in Crohn's Disease: A Systematic Review and Meta-Analysis of Randomized Trials and Real-World Evidence.

Alaa Abdrabou Abouelmagd et al.PubMed ↗Publisher ↗

No numbers read from the abstract.